NOVO B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Novo Nordisk is a producer of insulin for diabetes treatment. In addition to the specialist expertise in diabetes, the company produces drugs for hormone treatment as well as for hemophilia and bleeding disorders. The products are found on a global market and are sold under separate brands. Novo Nordisk was founded in 1923 and is headquartered in Bagsværd, Denmark.
Read moreRevenue B
EBIT-% (adj.)
EPS (adj.)
Dividend %
Interim report Q3'26
Don't miss out - create an account and get all the possible benefits
